PRESS RELEASE published on 06/18/2026 at 18:30, 4 months 26 days ago Inside Information / Other news releases Theraclion announces changes in its Board of Directors with Mr. Yann Duchesne stepping down and new appointments made. New Interim Chairman appointed. Details on the company's MedTech advancements Board Of Directors MedTech Theraclion SONOVEIN HIFU
PRESS RELEASE published on 06/18/2026 at 18:30, 4 months 26 days ago Informations privilégiées / Autres communiqués THERACLION annonce l'évolution de son conseil d'administration avec le départ de M. Yann Duchesne et la nomination d'un nouveau CA et d'un président par intérim Conseil D'administration Theraclion SONOVEIN Yann Duchesne Claude Lenoir
BRIEF published on 12/09/2025 at 18:35, 11 months 5 days ago Theraclion Submits Sonovein to FDA After Year of Key Achievements FDA Submission Clinical Evidence SONOVEIN Regulatory Achievements Varicose Vein Treatment
BRIEF published on 12/09/2025 at 18:35, 11 months 5 days ago Theraclion submits Sonovein to the FDA after significant progress FDA Theraclion SONOVEIN Varicose Veins HIFU
BRIEF published on 12/09/2025 at 18:35, 11 months 5 days ago Theraclion soumet Sonovein à la FDA après d'importants progrès FDA Theraclion SONOVEIN Varices HIFU
BRIEF published on 12/09/2025 at 18:35, 11 months 5 days ago Theraclion soumet le Sonovein à la FDA après une année de succès clés Soumission À La FDA SONOVEIN Réalisations Réglementaires Traitement Des Varices Preuves Cliniques
PRESS RELEASE published on 12/09/2025 at 18:30, 11 months 5 days ago Informations privilégiées / Autres communiqués Theraclion annonce la soumission de Sonovein à la FDA après une année de progrès réglementaires et cliniques, avec des résultats encourageants et des avancées significatives en Europe et en Chine FDA Theraclion SONOVEIN Varices HIFU
PRESS RELEASE published on 12/09/2025 at 18:30, 11 months 5 days ago Inside Information / Other news releases Theraclion announces FDA submission of Sonovein following a year of regulatory and clinical achievements. Key milestones in Europe and China also reached Clinical Milestones FDA Submission Theraclion SONOVEIN Regulatory Achievements
BRIEF published on 10/29/2025 at 18:35, 1 year ago Theraclion annonce ses résultats financiers et ses progrès stratégiques pour le premier semestre 2025. Résultats Financiers Croissance Des Revenus Expansion Du Marché Étude Américaine Progression De La Certification
BRIEF published on 10/29/2025 at 18:35, 1 year ago Theraclion Announces 2025 Half-Year Financial Results and Strategic Progress Financial Results Revenue Growth Market Expansion U.S. Study Certification Progress
Published on 11/14/2026 at 12:56, 22 hours 19 minutes ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 1 day 9 hours ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day 10 hours ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day 10 hours ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day 11 hours ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day 11 hours ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 13 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 16 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 16 hours ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 1 day 23 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 day 23 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 2 days 3 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 12 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)
